Loading...

Home
ETF
PSTV

PSTV

-

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

Overview Technical News

Most Trusted AI Platform for Winning Trades

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

Home
Contact
About Us
Press
Privacy
Terms of Service
Service Terms of Use

Resources

Blog
Tutorial
Help Center
Affiliate Program

Markets

Market Analysis
Crypto
Featured Screeners
AI Earnings Calendar
Market Movers
Stock Monitor
Economic Calendar
All US Stocks
All Cryptos

Tools

Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator

Features

QuantAI Alpha Pick
SwingMax Portfolio
Swing Trading
AI Stock Picker
Whales Auto Tracker
Daytrading Center
Patterns Detection
AI Screener
Financial AI Agent
Backtesting Playground
AI Earnings Prediction
Stock Monitor
Technical Analysis

News

Overview
Top News
Daily Market Brief
Earnings Analysis
Newswire
Stock News
Crypto News
Institution News
Congress News
Monitor News

Compare

TradingView
SeekingAlpha

PSTV News

CNSide Enables Early Diagnosis, Reducing Healthcare Costs by 40%

5d agoNewsfilter

Plus Therapeutics Partners with Ephemeral to Develop AI-Driven CNS Oncology Platform

May 19 2026Newsfilter

Plus Therapeutics Q1 Earnings Report Analysis

May 15 2026seekingalpha

Plus Therapeutics Presents REYOBIQ Clinical Data at AANS Annual Meeting

May 08 2026Newsfilter

Plus Therapeutics Secures Medicare Enrollment for CNSide Diagnostics

May 07 2026Newsfilter

CNSide Diagnostics Secures Coverage Agreement with Blue Shield of California

Apr 28 2026Newsfilter

Plus Therapeutics Initiates Manufacturing Activities with SpectronRx

Apr 23 2026Newsfilter

Plus Therapeutics Appoints New Chief Development Officer

Apr 22 2026Newsfilter

Plus Therapeutics Stock Meets Nasdaq Minimum Bid Requirement

Apr 21 2026seekingalpha

Plus Therapeutics Regains Nasdaq Compliance with Minimum Bid Price

Apr 21 2026Newsfilter

Plus Therapeutics Appoints New VP of Value Strategy

Apr 15 2026Newsfilter

Plus Appoints New Chief Development Officer and Receives FDA Approval

Apr 10 2026stocktwits

Plus Therapeutics Appoints New Chief Development Officer

Apr 09 2026Newsfilter

Plus Therapeutics Receives FDA Orphan Drug Designation

Apr 08 2026Newsfilter

Plus Therapeutics Secures New CPT Code for CNSide Test

Apr 07 2026Newsfilter

Plus Therapeutics Secures New Payer Agreement with Highmark

Apr 02 2026Newsfilter